pyrroles has been researched along with Hypertension, Portal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhull, P; Kumar, KV; Patnaik, SK; Upreti, V | 1 |
| Bosch, J; García-Cardeña, G; García-Pagán, JC; Gracia-Sancho, J; Hide, D; Marrone, G; Rosado, E; Russo, L | 1 |
| Aeed, H; Bruck, R; Gavish, D; Sharvit, E; Shirin, H | 1 |
| Angermayr, B; Bosch, J; Fernandez, M; Garcia-Pagan, JC; Mejias, M; Rodés, J | 1 |
| Abraldes, JG; Groszmann, RJ; Haq, O; Iwakiri, Y; Loureiro-Silva, M; Sessa, WC | 1 |
| Arroyo, V; Carmeliet, P; Fernandez-Varo, G; Friedman, SL; Jiménez, W; Morales-Ruiz, M; Muñoz-Luque, J; Rodés, J; Ros, J; Tugues, S | 1 |
6 other study(ies) available for pyrroles and Hypertension, Portal
| Article | Year |
|---|---|
An unusual cause of delayed puberty: Berardinelli- Seip syndrome.
Topics: Administration, Cutaneous; Adolescent; Atorvastatin; Combined Modality Therapy; Diet, Fat-Restricted; Drug Therapy, Combination; Estrogens; Exercise Therapy; Female; Fenofibrate; Fish Oils; Heptanoic Acids; Humans; Hypertension, Portal; Hypertriglyceridemia; Insulin; Insulin Resistance; Lipodystrophy, Congenital Generalized; Pioglitazone; Propranolol; Puberty, Delayed; Pyrroles; Thiazolidinediones; Treatment Outcome | 2012 |
The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins.
Topics: Animals; Atorvastatin; Cell Communication; Disease Models, Animal; Endothelial Cells; Gene Expression; Hepatic Stellate Cells; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Kruppel-Like Transcription Factors; Liver; Liver Circulation; Liver Cirrhosis, Experimental; Lovastatin; Male; Paracrine Communication; Pyrroles; Rats; Rats, Wistar; Simvastatin; Stress, Mechanical | 2013 |
Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats.
Topics: Animals; Atorvastatin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Fluorobenzenes; Hepatic Stellate Cells; Heptanoic Acids; Hypertension, Portal; In Vitro Techniques; Incidence; Injections; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Oxidative Stress; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Thioacetamide | 2013 |
Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
Topics: Angiogenesis Inhibitors; Animals; Arterioles; Collateral Circulation; Hemodynamics; Hypertension, Portal; Indoles; Male; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Portal System; Portal Vein; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Splanchnic Circulation; Vascular Endothelial Growth Factor Receptor-2; Vascular Resistance | 2005 |
Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state.
Topics: Angiogenesis Inhibitors; Animals; Endothelium, Vascular; Hypertension, Portal; Indoles; Intestinal Mucosa; Intestines; Jejunum; Male; Microcirculation; Neovascularization, Pathologic; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Portal Pressure; Pyrroles; Rats; Up-Regulation; Vascular Endothelial Growth Factor A; Vasodilation | 2006 |
Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.
Topics: Angiogenesis Inhibitors; Animals; Cells, Cultured; Disease Models, Animal; Hypertension, Portal; Indoles; Inflammation; Liver Cirrhosis; Male; Portal Pressure; Pyrroles; Rats; Rats, Wistar; Sunitinib | 2007 |